Selexipag
Active substance: selexipag
TABLET, FILM COATED · SELEXIPAG 1400 ug/1
United StatesActive
Marketing holder: Zydus Lifesciences Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SELEXIPAG · 1400 ug/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-45ff-7ce2-9cfe-d2b9c82b1a70,01a1208c-bb5c-76d0-9383-a070e346f46e,01a1208c-bcca-71e0-b66b-49e1d020e12d,01a1208c-bccc-7d61-8a65-dd8c3dab8d73,01a1208c-f5d6-7e87-9bfa-089937645f8f;count=40 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70771-1799
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 70771-1799 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70771-1799 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70771-1799 · Verified 2026-10-09 · open in source